Advertisement

© 2017

Drug Resistance in Bacteria, Fungi, Malaria, and Cancer

  • Gunjan Arora
  • Andaleeb Sajid
  • Vipin Chandra Kalia
Book

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Gunjan Arora, Ankur Kulshreshtha, Kriti Arora, Puneet Talwar, Rishi Raj, Gurpreet Grewal et al.
    Pages 1-24
  3. Shilpa Ray, Susmita Das, Mrutyunjay Suar
    Pages 47-110
  4. Prathusha Kakarla, Ranjana KC, Ugina Shrestha, Indrika Ranaweera, Mun Mun Mukherjee, T. Mark Willmon et al.
    Pages 111-140
  5. Brijendra Kumar Tiwari, Gunjan Kak, Deepika Sharma, Krishnamurthy Natarajan
    Pages 141-159
  6. Bhagwan Rekadwad, Juan M. Gonzalez, Chandrahasya N. Khobragade
    Pages 161-169
  7. Anil Kumar, Nikita Chordia
    Pages 171-192
  8. Lili Liang, Yun Ma, Xin liu, Yamin Lv
    Pages 193-208
  9. Gail E. Louw, Samantha L. Sampson
    Pages 233-262
  10. Daniel Ryan, Sangeeta Jaiswal, Mrutyunjay Suar
    Pages 287-305
  11. Richa Misra, Richa Virmani, Darshan Dhakan, Abhijit Maji
    Pages 325-338
  12. Vipin Chandra Kalia, Ravi Kumar, Shikha Koul
    Pages 339-355
  13. Ravi Kumar, Shikha Koul, Vipin Chandra Kalia
    Pages 357-370
  14. Pawan Kumar, Chitra Latka, Bhupesh Taneja
    Pages 371-385
  15. Preetida J. Bhetariya, Neha Sharma, Pragati Singh, Priyanka Tripathi, Santosh K. Upadhyay, Poonam Gautam
    Pages 387-428
  16. Santosh C. M. Kumar
    Pages 429-447

About this book

Introduction

This book is a compilation of past and recent knowledge in the field of emerging drug resistance. The book covers major aspects of drug resistance in bacteria, fungi, malaria, and cancer.
Human survival on earth is constantly threatened by disease and syndrome. From the early days, the aim of research in medicine was to find therapeutic agents that can improve the quality of human life. Although humans are dependent on natural compounds from early days their dependence of drugs increased excessively in last century. The advances in chemistry and biology have helped researchers to identify the drugs that have improved treatment of many diseases. The primary factor for treatment of these diseases is dependent on the efficacy of drugs available. The development of resistance to these drugs is one of the major hindrances. Although there are number of books available on this topic, “drug resistance” biology across kingdoms has never been discussed in a coherent way.

Keywords

Antibiotics Cancer Drug discovery Drug resistance Immune system

Editors and affiliations

  • Gunjan Arora
    • 1
  • Andaleeb Sajid
    • 2
  • Vipin Chandra Kalia
    • 3
  1. 1.CSIR - Institute of Genomics and Integrative BiologyDelhiIndia
  2. 2.National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA
  3. 3.CSIR - Institute of Genomics and Integrative BiologyDelhiIndia

About the editors

Dr. Vipin Chandra Kalia is presently working as Chief Scientist, and is the Deputy Director, at Microbial Biotechnology and Genomics, CSIR-Institute of Genomics and Integrative Biology, Delhi. He is a Professor, AcSIR, who obtained his M.Sc. and Ph.D. in Genetics, from Indian Agricultural Research Institute, New Delhi. He has been elected as: (1) Fellow of the National Academy of Sciences (FNASc), (2) Fellow of the National Academy of Agricultural Sciences (FNAAS), and (3) Fellow of the Association of Microbiologists of India (FAMI). His main areas of research are Microbial biodiversity, Bioenergy, Biopolymers, Genomics, Microbial evolution, Quorum sensing, Quorum quenching, Drug discovery and Antimicrobials. He has published 99 papers in Scientific journals such as (1) Nature Biotechnology, (2) Biotechnology Advances, (3) Trends in Biotechnology, (4) Annual Review of Microbiology, (5) Critical Reviews in Microbiology, (6) Bioresource Technology, (7) PLoS ONE, (8) BMC Genomics, (9) International Journal of Hydrogen Energy, and (10) Gene. He has authored 14 book chapters. His works have been cited 3267 times with an h index of 31 and an i10 index of 59. He has Edited 3 books: (i) Quorum Sensing vs Quorum Quenching: A Battle with No End in Sight (2015), (ii) Microbial Factories   Vol.  1: Biofuels, Waste treatment (2015) and (iii) Microbial Factories   Vol. 2:  Biodiversity, Biopolymers, Bioactive Molecules (2015). He is presently the Editor-in-Chief of the Indian Journal of Microbiology and editor of: (1) Journal of Microbiology & Biotechnology (Korea), (2) International Scholarly Res. Network Renewable Energy, (3) Dataset Papers in Microbiology, and (4) PLoS ONE. He is a life member of the following Scientific societies: (1) Society of Biological Chemists of India (2) Society for Plant Biochemistry and Biotechnology, India; (3) Association of Microbiologists of India; (4) Indian Science Congress Association; (5) BioEnergy Society of India, and (6) the Biotech Research Society of India (BRSI). He is also a member of the American Society for Microbiology.

Bibliographic information

Industry Sectors
Biomedicine
Pharma